Life Technologies reported $20.31M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Ardelyx USD 112.06M 4.06M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Cipla INR 54.32B 687.8M Jun/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.69M 736K Jun/2025
CSL USD 5.72B 173M Dec/2024
Galapagos EUR 122.32M 111.37M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Grifols EUR 1.6B 128.03M Dec/2024
Life Technologies USD 20.31M 4.49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
United Therapeutics USD 521.7M 110.1M Jun/2025